نتایج جستجو برای: ژن tp63

تعداد نتایج: 16672  

2017
Sankari Nagarajan Upasana Bedi Anusha Budida Feda H. Hamdan Vivek Kumar Mishra Zeynab Najafova Wanhua Xie Malik Alawi Daniela Indenbirken Stefan Knapp Cheng-Ming Chiang Adam Grundhoff Vijayalakshmi Kari Christina H. Scheel Florian Wegwitz Steven A. Johnsen

Bromodomain-containing protein 4 (BRD4) is a member of the bromo- and extraterminal (BET) domain-containing family of epigenetic readers which is under intensive investigation as a target for anti-tumor therapy. BRD4 plays a central role in promoting the expression of select subsets of genes including many driven by oncogenic transcription factors and signaling pathways. However, the role of BR...

Journal: :Cancer research 2013
Amanda L Balboni Justine A Hutchinson Andrew J DeCastro Pratima Cherukuri Karen Liby Michael B Sporn Gary N Schwartz Wendy A Wells Lorenzo F Sempere Paul B Yu James DiRenzo

Genetic analysis of TP63 indicates that ΔNp63 isoforms are required for preservation of regenerative stasis within diverse epithelial tissues. In squamous carcinomas, TP63 is commonly amplified, and ΔNp63α confers a potent survival advantage. Genome-wide occupancy studies show that ΔNp63 promotes bidirectional target gene regulation by binding more than 5,000 sites throughout the genome; howeve...

2012
George Vasmatzis Sarah H Johnson Ryan A Knudson Rhett P Ketterling Esteban Braggio Rafael Fonseca David S Viswanatha Mark E Law N Sertac Kip Nazan Özsan Stefan K Grebe Lori A Frederick Bruce W Eckloff E Aubrey Thompson Marshall E Kadin Dragana Milosevic Julie C Porcher Yan W Asmann David I Smith Irina V Kovtun Stephen M Ansell Ahmet Dogan Andrew L Feldman

Peripheral T-cell lymphomas (PTCLs) are aggressive malignancies of mature T lymphocytes with 5-year overall survival rates of only ~35%. Improvement in outcomes has been stymied by poor understanding of the genetics and molecular pathogenesis of PTCL, with a resulting paucity of molecular targets for therapy. We developed bioinformatic tools to identify chromosomal rearrangements using genome-w...

2017
Zehang Zhuang Nan Xie Jing Hu Pei Yu Cheng Wang Xingxue Hu Xiaozhe Han Jinsong Hou Hongzhang Huang Xiqiang Liu

TP63 acts as a master regulator in epithelia development and in the progression of various cancers, but its role in oral cancer pathogenesis remains unknown. This study aimed to explore the role of TP63 in the progression of oral squamous cell carcinoma (OSCC). This study shows that ΔNp63, the predominant isoform of TP63, is significantly upregulated in OSCC tissues and cell lines compared with...

Journal: :Blood 2014
Edgardo R Parrilla Castellar Elaine S Jaffe Jonathan W Said Steven H Swerdlow Rhett P Ketterling Ryan A Knudson Jagmohan S Sidhu Eric D Hsi Shridevi Karikehalli Liuyan Jiang George Vasmatzis Sarah E Gibson Sarah Ondrejka Alina Nicolae Karen L Grogg Cristine Allmer Kay M Ristow Wyndham H Wilson William R Macon Mark E Law James R Cerhan Thomas M Habermann Stephen M Ansell Ahmet Dogan Matthew J Maurer Andrew L Feldman

Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a CD30-positive T-cell non-Hodgkin lymphoma that morphologically resembles ALK-positive ALCL but lacks chromosomal rearrangements of the ALK gene. The genetic and clinical heterogeneity of ALK-negative ALCL has not been delineated. We performed immunohistochemistry and fluorescence in situ hybridization on 73 ALK...

Journal: :Journal of medical genetics 2003
I Dianzani E Garelli P Gustavsson A Carando B Gustafsson N Dahl G Annerén

I ncreases in the number of allelic malformation syndromes (due to mutations in a single gene) have led to their classification according to their pathogenesis rather than their clinical specific phenotype. TP63 mutations have been identified in several such syndromes characterised by autosomal dominant transmission and various combinations of ectodermal dysplasia, limb malformations, and orofa...

Journal: :International Journal of Molecular Sciences 2021

2003
I Dianzani E Garelli G Annerén

I ncreases in the number of allelic malformation syndromes (due to mutations in a single gene) have led to their classification according to their pathogenesis rather than their clinical specific phenotype. TP63 mutations have been identified in several such syndromes characterised by autosomal dominant transmission and various combinations of ectodermal dysplasia, limb malformations, and orofa...

2013
Nelson H. F. Beebe

10 [Hel81, Mei81]. 1004 [Mil87b]. 1040 [Lin88]. 11 [Muf88]. 1113 [Lin89]. 112 [Nat85a]. 113 [Nat85b]. 12 [Bv82]. 121 [Hun85, Wic87]. 1413 [Joh93]. 1421 [Lin93]. 1500-1815 [TP63]. 15th [IEE74]. 18 [Riv79]. 1917 [FM76]. 1939-1945 [Jon78]. 1941 [MB86]. 1942 [Uni79b]. 1944 [ML87]. 1945 [Uni79b]. 1976 [BGK77]. 1977 [Uni78a]. 1981 [BBB81]. 1982 [IEE82b]. 1983 [Bur81, Fêa83, Had84]. 1984} [San86, BCI8...

2014
Silvia Pineda Roger L. Milne M. Luz Calle Nathaniel Rothman Evangelina López de Maturana Jesús Herranz Manolis Kogevinas Stephen J. Chanock Adonina Tardón Mirari Márquez Lin T. Guey Montserrat García-Closas Josep Lloreta Erin Baum Anna González-Neira Alfredo Carrato Arcadi Navarro Debra T. Silverman Francisco X. Real Núria Malats

INTRODUCTION Germline variants in TP63 have been consistently associated with several tumors, including bladder cancer, indicating the importance of TP53 pathway in cancer genetic susceptibility. However, variants in other related genes, including TP53 rs1042522 (Arg72Pro), still present controversial results. We carried out an in depth assessment of associations between common germline variant...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید